Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb/III randomized double-blind placebo-controlled study of MK-0941 in type 2 diabetes
2008-002121-36Phase 2Completed
- Sponsor
- MSD
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing MK-0941 with Placebo (2 arms). Primary endpoint: HbA1c change at 14 weeks. Started Jun 2008; status: completed.
02
Drugs
mk-0941
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-002121-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002121-36.